Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ana Gonzalez Reiche"'
Autor:
Alberto Paniz‐Mondolfi, Susana Guerra, Marina Muñoz, Nicolas Luna, Matthew M. Hernandez, Luz H. Patino, Jason Reidy, Radhika Banu, Paras Shrestha, Bernadette Liggayu, Audrey Umeaku, Feng Chen, Liyong Cao, Armi Patel, Ayman Hanna, Sunny Li, Andy Look, Nina Pagani, Randy Albrecht, Rebecca Pearl, Adolfo Garcia‐Sastre, Dusan Bogunovic, Gustavo Palacios, Lucia Bonnier, Freddy Cera, Heidi Lopez, Yvette Calderon, Erick Eiting, Karr Mullen, Sangyoon Jason Shin, Luz Amarilis Lugo, Antonio E. Urbina, Carlotta Starks, Tonny Koo, Patricia Uychiat, Avery Look, Harm van Bakel, Ana Gonzalez‐Reiche, Adolfo Firpo Betancourt, David Reich, Carlos Cordon‐Cardo, Viviana Simon, Emilia M. Sordillo, Juan David Ramírez
Publikováno v:
Journal of medical virologyREFERENCES. 95(1)
Monkeypox virus (MPXV) is a zoonotic orthopoxvirus within the Poxviridae family. MPXV is endemic to Central and West Africa. However, the world is currently witnessing an international outbreak with no clear epidemiological links to travel or animal
Autor:
Ana Gonzalez-Reiche
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have been reported in immune-compromised individuals and people undergoing immune-modulatory treatments. Although intrahost evolution has been documented, to our knowl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b8f6b2a15036f0e7ec2bf04620fef0f
https://doi.org/10.1101/2022.05.25.22275533
https://doi.org/10.1101/2022.05.25.22275533
Autor:
Teresa Aydillo, Ana Gonzalez-reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan Nair, Chiara Mariottini, Stuart Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo Garcia-Sastre
A phase 1 clinical trial to test the immunogenicity of a chimeric group 1 HA (cHA) universal influenza virus vaccine targeting the conserved stalk domain of the hemagglutinin of influenza viruses was carried out. Vaccination with adjuvanted-inactivat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33f23c528c0134767f6b2d81943fd84b
https://doi.org/10.21203/rs.3.rs-1547761/v1
https://doi.org/10.21203/rs.3.rs-1547761/v1
Autor:
Ania Wajnberg, Willemijn Rijnink, Juan Manuel Carreño, Daniel C. Adelsberg, Giulio Kleiner, Carolina Bermúdez-González, Aaron J. Schmitz, Goran Bajic, Kayla T. Russo, Florian Krammer, Lubbertus C. F. Mulder, Levy A. Sominsky, Denise Jurczyszak, Fatima Amanat, Katherine Beach, Ashley Beathrese T. Salimbangon, Julia C. Matthews, Shaza M. Sayed Ahmed, Emilia Mia Sordillo, Shirin Strohmeier, Komal Srivastava, Mahima Thapa, Tinting Lei, Miti Saksena, Wanni A. Mendez, Deena R. Altman, Harm van Bakel, Lily Q. Eaker, Daniel L. Floda, Jackson S. Turner, Charles R Gleason, Shelcie Fabre, Sarah Zafar, Sayahi Suthakaran, Mahmoud Awawda, Rachel Chernet, Bulbul Ahmed, Viviana Simon, Ali H. Ellebedy, Julian Q. Zhou, Angela Amoako, Ana Gonzalez Reiche, Jose Polanco, Emily D. Ferreri, Hala Alshammary, Amber S. Shin, Nicholas Borcherding
Publikováno v:
Cell
In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded thos